From the Journals

High or low birth weight in pediatric NAFLD may increase disease severity


 

FROM THE JOURNAL OF PEDIATRICS

Among children with nonalcoholic fatty liver disease (NAFLD), those with high birth weight had significantly greater odds of having more severe steatosis and nonalcoholic steatohepatitis (NASH) than those with normal birth weight, reported Kimberly P. Newton, MD, of the University of California, San Diego, and her associates.

In contrast, the children with low birth weight had twice the risk of advanced fibrosis, compared with those with normal birth weight.

Nonalcoholic fatty liver disease Courtesy of Wikimedia / "Nephron" / Creative Commons License
This study used the database of the National Institute of Diabetes and Digestive and Kidney Diseases NASH Clinical Research Network. Birth weights were categorized as low birth weight (LBW) at 1,500 g-2,499 g, normal birth weight (NBW) at 2,500 g-3,999 g, or high birth weight (HBW) at 4,000 g or greater.

Of 538 children with a mean age of 13 years, 9% had LBW, 76% had NBW, and 15% had HBW. Definite NASH was present in 27%.

Of the HBW children, 51% had severe steatosis, and those with HBW had significant 1.82-times greater odds of having severe steatosis than those with NBW. There was no significant difference in severe steatosis between children with LBW and NBW.

The odds of having NASH were two-times higher in the HBW children, compared with NBW children. The prevalence of NASH did not differ between the LBW and NBW children. The children with LBW had 2.23-times greater odds of advanced fibrosis, compared with the NBW children. There was no significant difference in advanced fibrosis between the HBW and NBW children.

“The frequency of children born with HBW has greatly increased recently, in parallel with the epidemic of obesity, and, thus, implications of HBW for future health have not been fully characterized,” Dr. Newton and her colleagues. The results of this study suggest there may be long-lasting hepatic consequences.

Read more in the Journal of Pediatrics (2017 Mar 30. doi: 10.1016/j.jpeds.2017.03.007).

Recommended Reading

VIDEO: Study estimates prevalence of pediatric celiac disease, autoimmunity
MDedge Pediatrics
FDA approves Sovaldi, Harvoni for HCV in ages 12-plus
MDedge Pediatrics
Avoid laxatives or stool softeners prior to C. difficile test in ped in patients
MDedge Pediatrics
CDC: Some Shigella strains show reduced ciprofloxacin susceptibility
MDedge Pediatrics
Revaccinate HIV-infected teens with hepatitis B vaccine
MDedge Pediatrics
DTC genetic health risk tests: Beware
MDedge Pediatrics
Rotavirus vaccination in last decade cuts AGE hospitalization
MDedge Pediatrics
Breast milk bacteria seed infant gut microbiome
MDedge Pediatrics
HMGB1 might be new biomarker of celiac disease in children
MDedge Pediatrics
Constipation implicated as an indicator of Helicobacter pylori infection
MDedge Pediatrics